To better understand melanoma resistance to herpes simplex virus type 1 (HSV-1)-mediated oncolysis, traditional two-dimensional (2D) cultures and extracellular matrix (ECM) containing three-dimensional (3D) cultures of OCM1 and C918 uveal melanoma cells were infected with an HSV-1 strain that expresses the green fluorescent protein (GFP) marker during replication. Although 2D cultures were completely destroyed within a few days of HSV-1 inoculation, viable GFP-negative tumor cells remained detectable in 3D cultures for several weeks. Tumor cells with increased resistance to HSV-1 included cells that formed vasculogenic mimicry patterns and multicellular spheroids and cells that invaded Matrigel individually. Mechanisms of tumor resistance against HSV-1 in the 3D environment included impaired virus spread in the ECM and ECM-mediated inhibition of viral replication after viral entry into tumor cells. Observations also suggested that HSV-1 established quiescent infection in some tumor cells present in multicellular spheroids and that this could revert to productive viral infection when the tumor growth pattern changed. These findings indicate that 3D tumor cell cultures can be used to identify distinct tumor cell populations with increased resistance to HSV-1 and to explore mechanisms of ECM-mediated tumor resistance to oncolytic virotherapy.
Introduction
Virus, including herpes simplex virus type 1 (HSV-1)-mediated oncolytic therapy, is a promising novel modality of tumor therapy with potential usefulness against a wide variety of malignancies. [1] [2] [3] [4] [5] [6] Oncolytic HSV-1 therapy is dependent on virus replication in tumor cells and is augmented by host antiviral and infection-induced anti-tumor immune responses. [7] [8] [9] [10] [11] In spite of significant progress, oncolytic virotherapy faces significant challenges. Although traditional two-dimensional (2D) monolayer cultures of many types of tumor cells are efficiently destroyed by a variety of HSV-1 vectors in vitro, tumor destruction is often incomplete in vivo. 1, 7 Factors limiting the effectiveness of HSV-1 oncolytic therapy in vivo remain incompletely understood. However, observations indicate that potential problems include the impairment of intratumoral virus spread by the extracellular matrix (ECM), decreased expression of viral entry receptors by different tumor cell populations, activation of intracellular tumor defenses to viral infection, and quick virus clearance by the host immune system. 7, [12] [13] [14] [15] [16] [17] [18] [19] It is clear that many aspects of the complex virus-host interactions that determine the effectiveness of HSV-1 oncolytic therapy are difficult to impossible to study in traditional 2D tissue culture systems.
The behavior of cells in vivo is controlled by their interactions with neighboring cells and with the ECM. [20] [21] [22] [23] Cancer cells grown in three-dimensional (3D) cultures in a polymeric ECM closely mimic the biology of tumor development in vivo and numerous studies indicate that 3D cultures are superior to traditional 2D monolayer cultures for studies of key cellular behaviors such as differentiation, proliferation, invasion, and apoptosis. [23] [24] [25] [26] [27] [28] [29] Cancer cells grown in 3D culture are more resistant to chemotherapeutic agents and radiation than cells in 2D culture and 3D tumor cell cultures are useful for preclinical evaluation of the cytotoxic effect of anticancer agents. 25, 27, 30 It is well established that multiple cell types within individual tumors have differential sensitivities to drugs and radiation both in vivo and in 3D cultures.
Although 3D cultures provide an excellent experimental system to study mechanisms of tumor cell resistance to drugs and radiation, very few studies have used 3D tumor cell cultures in the context of viral oncolytic therapy. 19, 32, 33 Earlier work in our laboratory indicated that 3D cultures of uveal melanoma cells show increased resistance to HSV-1 relative to 2D cultures. 33 Specifically, destruction of 95% of tumor cells occurred several days later in 3D cultures than in 2D cultures after HSV-1 inoculation. These findings suggested that HSV-1 inoculation of 3D uveal melanoma cultures could provide a useful model to study mechanisms of ECM-mediated tumor resistance to HSV-1 oncolytic therapy.
The ECM environment is a critically important determinant of the morphology and gene expression profile of uveal melanomas in vivo and of uveal melanoma cultures in vitro. [34] [35] [36] [37] [38] [39] Highly invasive uveal melanoma cells, including C918 cells, and uveal melanoma cells of low invasive potential, including OCM1 cells, all grow as monolayers in 2D cultures. In 3D cultures established with the use of laminin-rich ECM (Matrigel), highly invasive uveal melanoma cells form vasculogenic mimicry patterns. In contrast, uveal melanoma cells of low invasive potential do not form vasculogenic mimicry patterns under 3D conditions, but rather grow in tumor cell aggregates on the matrix surface and form multicellular spheroids inside the matrix. In addition to these structures, 3D cultures of uveal melanoma cells contain a variety of other morphologically distinguishable cell populations that are defined by their spatial relationship to the ECM. For instance, 3D cultures of both highly invasive uveal melanoma cells and uveal melanoma cells of low invasive potential contain individual tumor cells invading the ECM. Observations indicate that morphologically distinct tumor cell populations present in 3D cultures are of clinical relevance. For instance, vasculogenic mimicry patterns are present in a wide variety of malignancies including uveal melanomas and their detection is associated with increased mortality. 34, 37 This study has used 2D and 3D cultures of uveal melanoma cells and was designed to find answers to the following questions related to HSV-1 oncolytic therapy. (i) Can 3D tumor cell cultures be used to identify morphologically distinct tumor cell populations that have increased resistance to HSV-1? (ii) Can 3D tumor cell cultures be used to learn about mechanisms of ECMmediated tumor cell resistance to HSV-1 oncolytic therapy?
We show here that 3D tumor cell cultures can be used to identify distinct tumor cell populations with increased resistance to HSV-1 oncolytic therapy. We report that uveal melanoma cell populations with increased resistance to HSV-1 in 3D cultures include cells forming vasculogenic mimicry patterns and multicellular spheroids and tumor cells that invade the ECM individually. Furthermore, we show that mechanisms of tumor resistance against HSV-1 in the 3D environment include impaired virus spread in the Matrigel matrix and ECM-mediated inhibition of viral replication after viral entry into tumor cells.
Materials and methods

Viruses
Wild-type (wt) HSV-1 strain KOS and recombinant HSV-1 strain K26GFP (a gift from P Desai, The Johns Hopkins University, Baltimore, MD) were amplified and quantitated as described elsewhere. 40, 41 Cells infected with HSV-1 strain K26GFP exhibit punctate nuclear fluorescence at early times in the replication cycle and at later times during infection, a generalized cytoplasmic and nuclear fluorescence, including fluorescence at the cell membranes can be observed. 40 K26GFP was shown to grow wt virus as well in cell culture. 40 
Cells
Uveal melanoma cells of low (OCM1) and high (C918) invasive potential were maintained in Eagle's Minimal Essential Medium (BioWhittaker Inc., Walkersville, MD) supplemented with heat inactivated 15% fetal bovine serum (Fisher, Ontario, Canada) without the addition of exogenous ECM molecules or growth factors. These cell lines have been described in detail earlier. 38, 39, 42 2D and 3D uveal melanoma cultures Melanoma cells were grown on six-well plates in Eagle's Minimal Essential Medium medium either in the presence (3D cultures) or in the absence (2D cultures) of ECM rich in laminin (Matrigel, BD Biosciences, Bedford, MA). For 3D cultures, Matrigel was poured onto tissue culture plates to a depth of approximately 0.2 mm followed by polymerization for 1 h at 37 1C before placement of melanoma cells on the Matrigel surface. Cultures were incubated in repeatedly refreshed culture medium for up to 4 weeks and observed daily under an inverted microscope (Leica, Bannockburn, IL).
Determination of susceptibility of uveal melanoma cells to wt HSV-1 (KOS) and HSV-1 K26GFP-mediated destruction in 2D and 3D cultures C918 and OCM1 uveal melanoma cells were grown on six-well tissue culture plates in the presence (3D cultures) or absence of Matrigel (2D cultures). After 3-4 days, when in the 3D cultures C918 cells formed prominent vasculogenic mimicry patterns and OCM-1 cells formed cell aggregates on the Matrigel surface and both cell lines showed invasion of tumor cells into the Matrigel matrix, the tissue culture medium was removed and one of the following inocula was gently placed on the surface of the cultures: (i) 0.5 ml of sterile PBS (mock infection); (ii) wt HSV-1 (strain KOS) with a calculated multiplicity of infection (MOI) of 0.5 plaque forming units (PFU) per cell diluted in PBS to a final volume of 0.5 ml; (iii) HSV-1 K26GFP with a calculated MOI of 0.5 PFU per cell diluted in PBS to a final volume of 0.5 ml. After incubation for 1 h, the original inocula were removed and fresh tissue culture medium (3 ml) was added to each well and further incubated in repeatedly refreshed culture medium for up to 4 weeks. During this 4-week period, cultures were observed daily under an inverted fluorescence microscope (Leica, Bannockburn, IL) for evidence of viral cytopathic effects and green fluorescent protein (GFP) expression. The day when at least 95% of the melanoma cells were destroyed was noted. Cell death was confirmed by the uptake of the charged cationic dye Trypan blue (0.2%) by 495% of residual cells after incubation of cultures with Trypan blue (0.2%) for 10 min at 37 1C.
Determination of HSV-1 spread through Matrigel C918 and OCM1 uveal melanoma cells were grown on 12-well tissue culture plates in monolayers (2D cultures). When the cultures have reached approximately 70% confluency, culture media were removed and either 0.5 ml of a 1:1 mixture of PBS and Matrigel or 0.5 ml of PBS was layered on the cells. Cultures were then incubated at 37 1C for 1 h to allow Matrigel to polymerize and form an approximately 1 mm thick layer matrix on the cells. Next, cultures were either inoculated with 0.5 ml HSV-1 K26GFP diluted in PBS to a calculated MOI of 0.5 PFU per cell or were mock infected with 0.5 ml PBS by gently layering these solutions on the cultures making sure that the Matrigel surface was not violated. After further incubation at 37 1C for 1 h, additional 2 ml of fresh tissue culture media was added to each well. Cultures were then further incubated for up to 2 weeks at 37 1C with fresh culture medium added to the cultures every 2 days. During this 2-week period, cultures were observed regularly under an inverted fluorescence microscope (Leica, Bannockburn, IL) for evidence of GFP expression.
Placement and culturing of earlier HSV-1 inoculated uveal melanoma cells in 2D or 3D environments C918 and OCM1 uveal melanoma cells were grown on 12-well tissue culture plates in monolayers (2D cultures). When the cultures have reached approximately 70% confluency, culture media were removed and the cells were exposed at 37 1C to one of the following inocula: (i) 0.5 ml of sterile PBS (mock infection) or (ii) HSV-1 K26GFP with a calculated MOI of 0.5 PFU per cell diluted in PBS to a final volume of 0.5 ml. After incubation for 1 h, the original inocula were removed and the monolayers were washed in sterile PBS twice and 1 ml of sterile PBS was added to each well. Cells were than scraped off using sterile, disposable cell scrapers. Cell solutions were than centrifuged and cell pellets were resuspended in culture medium. Equal volumes (0.25 ml) of the cell solutions were then used to either establish new 2D cultures in 12-well tissue culture plates or 3D cultures as follows. For 3D cultures, Matrigel was poured onto tissue culture plates to a depth of approximately 0.2 mm followed by polymerization for 1 h at 37 1C Cell suspensions of HSV-1 K26GFP or mock-infected uveal melanoma cells were mixed with Matrigel 1:1 (0.25:0.25 ml) and poured on the Matrigel-coated wells. Finally, 2 ml of fresh culture medium was added. 2D and 3D cultures were then further incubated for up to 4 weeks at 37 1C with fresh culture medium added to the cultures every 2 days. During this 4-week period, cultures were observed regularly under an inverted fluorescence microscope (Leica, Bannockburn, IL) for evidence of GFP expression and the percentage of GFP-expressing cells was determined by counting the number of GFPpositive and GFP-negative cells in 16 high power microscopic fields for each studied type of treatment at selected time points. Figures 1e, 2c) . Tumor cell aggregates on the Matrigel surface also showed similar spheroid formation at their bottom portion that completely immersed in the Matrigel matrix (Figure 2b and c) . Many of the tumor cell spheroids were stable for days to weeks, whereas others showed outgrowth of individual cells into the matrix. Cells invading the matrix (Figure 1g ) eventually reached the bottom of the tissue culture plate and grew under the matrix in monolayers (Figure 2d ). The growth of OCM1 cells within the Matrigel matrix did not cause massive destruction of the matrix until the end of the 4-week observation period.
Results
OCM1
When C918 cells were placed on the Matrigel surface, the cells started to grow on the matrix surface in a single layer and formed circular vasculogenic mimicry patterns that surrounded round matrix surfaces free of tumor cells (Figures 1d, 3a) . Next, individual tumor cells started to grow into the Matrigel at the line defined by the vasculogenic mimicry patterns (Figures 1f, 3b) . Cells invading the matrix migrated to the bottom of the culture plate and formed monolayers there (Figures 1h, 3c  and d) . Interestingly, the formation of these bottom monolayers was restricted to areas that were under the Matrigel surfaces that were not colonized by cells and were surrounded by vasculogenic mimicry patterns ( Figure 3c ). Next, individual tumor cells invaded the matrix underlying cell monolayers on the Matrigel surface (Figure 3d ). Tumor cell growth and matrix invasion eventually caused a loss of Matrigel in areas surrounded by vasculogenic mimicry patterns (Figure 3d ).
These observations confirm and extend earlier observations related to the morphology uveal melanoma cultures 38 and indicate that OCM1 and C918 uveal melanoma cells form several morphologically distinct cell populations under 3D culture conditions. Rapid destruction of 2D and delayed and incomplete destruction of 3D uveal melanoma cultures by wt HSV-1 and HSV-1 K26GFP 2D and 3D cultures of OCM1 and C918 cells were inoculated with wt HSV-1 strain KOS or HSV-1 strain Virus resistance in 3D tumor cultures K Valyi-Nagy et al K26GFP by placing virus solutions on the surface of the cultures. HSV-1 K26GFP exhibits fluorescence on replication. 40 Cultures were followed for evidence of cytopathic effects and virus replication (GFP expression/fluorescence) by an inverted fluorescence microscope.
We found that 2D cultures were completely destroyed by both HSV-1 strains within a few days (Table 1) with no evidence of surviving cells by Trypan blue staining (data not shown). In contrast, virus inoculated 3D cultures showed delayed and incomplete destruction (Table 1) . Importantly, a portion of both OCM1 and C918 cells seemed to survive HSV-1 KOS and HSV-1 K26GFP infection in 3D cultures for up to 4 weeks. Cell populations with increased resistance included C918 cells that formed vasculogenic mimicry patterns on the Matrigel surface, OCM1 cells that formed multicellular spheroids within the Matrigel matrix, and both C918 and OCM1 cells that invaded Matrigel individually.
In K26GFP inoculated 2D OCM1 and C918 cultures, 20-50% of tumor cells showed GFP expression by 1 day post infection (p.i.), and after 3 days p.i., it was very difficult to find any cells without fluorescence consistent with the complete viral replication-mediated destruction of these cultures by 4-5 days (Figures 4a and b, 6a and b) . In contrast, 3D cultures of both OCM1 and C918 showed a significant number of GFP-negative cells throughout the 4-week observation period ( Figures  4c-h, 5a-f, 6c-h, 7a-f) .
In 3D cultures of OCM1, cells forming aggregates on the Matrigel surface showed widespread fluorescence (virus replication) by 1 day p.i., and after 4 days p.i., it was very difficult to find any cells without fluorescence in these structures consistent with the complete virusmediated destruction of these surface cell aggregates by K26GFP by 8 days p.i. (Figure 4c and d) . Individual OCM1 cells growing into the Matrigel matrix showed variable fluorescence and some apparently viable, and GFP-negative cells were consistently present during the 4-week observation period. Cells forming multicellular spheroids inside the matrix and cells forming spheroids at the bottom, matrix immersed portion of surface aggregates showed marked resistance to HSV-1 replication (Figures 4c-h, 5a and b) . Although occasional spheroids showed widespread fluorescence by 4 days p.i., others contained only a few GFP-positive cells and many remained completely devoid of GFP expression for days to weeks. GFP-negative spheroids contained viable cells as radial outgrowth of individual cells into the Matrigel matrix was observed from many of these structures as the cultures were aging (Figure 5a,c and e) . Interestingly, this outgrowth was often associated with the appearance of fluorescence in outgrowing cells and in cells within the spheroids (Figure 5d and f) , whereas in other cases, both spheroids and outgrowing cells remained GFP negative (Figure 5b ). Cells growing under the matrix in monolayers were susceptible to HSV-1 and showed widespread fluorescence.
In 3D cultures of C918 cells, cells growing on the matrix surface in a single layer showed widespread fluorescence (virus replication) as early as 1 day p.i. consistent with the complete destruction of this cell population by K26GFP by 9 days p.i. (Figure 6c and  d) . In contrast, cells forming vasculogenic mimicry Virus resistance in 3D tumor cultures K Valyi-Nagy et al patterns on the Matrigel surface showed increased resistance to HSV-1 (Figure 6e and f) and GFP-negative cells could be observed in these structures throughout the 4-week observation period. Similarly, cells invading the matrix individually showed increased resistance to HSV-1 and this cell population also included many GFP-negative cells throughout the 4-week observation period ( Figures   6g-h, 7a-f ). Tumor cells growing in monolayers under the Matrigel showed widespread fluorescence and susceptibility to HSV-1 (Figure 6e and f). These observations clearly identify certain uveal melanoma populations with increased resistance against HSV-1 in the 3D environment. Consequent experiments were designed to identify the mechanism(s) responsible for the 
Matrigel impairs HSV-1 spread
To determine whether inhibition of HSV-1 spread through Matrigel was a mechanism responsible for the absence of virus replication (GFP expression) in some tumor cells in 3D cultures, monolayers of OCM1 and C918 cells were covered with an approximately 1 mm thick layer of Matrigel and then HSV-1 K26GFP was placed on the Matrigel surface. As controls, monolayers of OCM and C918 cells without a Matrigel cover were also inoculated with the same amount of virus. Virus inoculated uveal monolayers with no Matrigel cover showed widespread GFP expression by 18-24 h p.i. and were completely destroyed within a few days. In contrast, cells covered with Matrigel and inoculated with HSV-1 K26GFP showed continued viability and growth during a 2-week observation period with no evidence of GFP expression. These findings indicate that Matrigel inhibits HSV-1 spread.
ECM mediates inhibition of HSV-1 replication after virus entry into tumor cells
To determine whether inhibition of viral replication after virus entry into tumor cells is a mechanism responsible for the absence of virus replication (GFP expression) in some tumor cells in 3D cultures, uveal melanoma cells were first inoculated with HSV-1 K26GFP under 2D conditions (allowing for unimpeded entry of virus into cells) and were then cultured under either 2D or 3D conditions. Briefly, C918 and OCM1 uveal melanoma cells grown in monolayers were either exposed to HSV-1 K26GFP at a calculated MOI of 0.5 PFU per cell or to sterile PBS (mock infection) for 1 h. The original inocula were then removed and the inoculated cells were scraped off and were resuspended in fresh culture medium. Equal volumes of the cell solutions were then used to either establish new Table 2) . Nearly all OCM1 cells were GFP positive by 72 h and nearly all C918 cells were GFP positive by 96 h. These findings are consistent with replication of input virus in infected cells at 18 h p.i. and virus spread to all cells in the following days.
Culturing of earlier HSV-1 K26GFP inoculated OCM1 and C918 cells in 3D was initially associated with single cells suspended in matrix. More than half of the cells showed morphologic changes during the first day of the establishment of the 3D cultures including rounding and a minority of cells showed morphological features of apoptosis. At 18 h p.i., the numbers of OCM1 and C918 cells in the virus-infected 3D cultures were 12.5 and 8.5% lower than those in their mock-infected 3D counterparts. At 18 h p.i., 2.80 ± 2.75% of OCM1 cells In HSV-1-infected 3D cultures, the majority of cells remained GFP negative throughout a 4-week observation period (data not shown). Interestingly, the outgrowth of individual OCM1 cells into the Matrigel matrix from spheroids that have been GFP negative for days to weeks was occasionally associated with the appearance of GFP expression in outgrowing cells and in cells within the spheroids similarly to the process shown in Figure 5c -f. As Matrigel does not allow HSV-1 spread, these observations suggest that HSV-1 established a quiescent infection in some tumor cells within multicellular spheroids and that this quiescent infection could revert to productive viral infection when the tumor growth pattern changed.
Discussion
We show here for the first time that 3D tumor cell cultures can be used to identify morphologically distinct tumor cell populations with increased resistance to HSV-1. Specifically, we show that tumor cells forming vasculogenic mimicry patterns and multicellular spheroids and cells that invade the ECM individually have increased resistance to HSV-1. Furthermore, we show that mechanisms of tumor resistance against HSV-1 in the 3D environment include impaired virus spread in the ECM and ECM-mediated inhibition of viral replication after viral entry into tumor cells. Observations reported here also suggest that HSV-1 can establish quiescent infection in some tumor cells present in multicellular spheroids and that this can revert to productive viral infection on outgrowth of individual tumor cells into the Matrigel matrix.
It is well established that 3D tumor cell cultures are useful for preclinical evaluation of the cytotoxic effect of anticancer agents, and multiple cell types within individual tumors have differential sensitivities to drugs and radiation both in vivo and in 3D cultures. 25, 27, 30, 31 However, so far very few studies have used 3D tumor cell cultures in the context of viral oncolytic therapy. These studies have indicated that tumor cells grown in 3D cultures are also more resistant to viral, including HSV-1 and adenovirus-mediated oncolytic therapy, than cells grown in 2D culture. 32, 33 Observations reported here confirm and extend these studies and identify morphologically distinct tumor cell populations present in 3D cultures that have increased resistance to viral oncolytic therapy. These observations are likely of clinical relevance as, for instance, vasculogenic mimicry patterns are present in a wide variety of malignancies and their detection in several tumor types is associated both with adverse outcome. 34, 37 Factors limiting the effectiveness of HSV-1 oncolytic therapy remain poorly understood in part because related studies have been limited to expensive and time-consuming experimental animal models. Theoretical considerations and experimental observations made thus far indicate that mechanisms of tumor resistance to HSV-1 therapy include ECM-mediated impairment of intratumoral virus spread, impaired viral entry into tumor cells because of decreased expression of HSV-1 entry receptors, inhibition of viral replication after viral entry into tumor cells, and virus clearance by the host immune system. [5] [6] [7] [12] [13] [14] [15] [17] [18] In this study, we found that at least two of these potential mechanisms of virus resistanceimpaired virus spread in the ECM and inhibition of viral replication after viral entry into tumor cells-are also relevant to 3D tumor cell cultures.
HSV-1 oncolysis can be improved by degradation of fibrillar collagen in tumors indicating that the ECM has an important function in determining treatment efficacy. 15 This study indicates that laminin-rich ECM, Matrigel inhibits HSV-1 spread. These findings are consistent with the earlier reported inhibition of HSV-1 spread by epithelial basement membrane in vivo and by Matrigel in vitro. 43 It is important to note that HSV-1 could clearly infect and replicate in some uveal melanoma cells that have invaded the Matrigel matrix in this study. These observations indicate that HSV-1 can spread through Matrigel if tumor cells infiltrating the ECM are present. Whether HSV-1 can spread from cell to cell within the Matrigel matrix through intercellular contacts or through spaces in Matrigel created by growing tumor cells remains unclear at this point.
This study also indicates that inhibition of viral replication at a stage beyond viral entry is an important mechanism by which the ECM can modulate viral replication in tumors. It is well known that adhesion of cancer cells to the ECM mediates drug and radiation resistance. 27, 29, 44 The connection of tumor cells to ECM proteins such as collagen and laminin through cell adhesion molecules, in particular integrin receptors, is associated with tumor cell survival and drug resistance through the activation of a variety of signaling pathways. It is unclear at this point to what extent, if any, mechanisms of drug and radiation resistance in 3D tumor cell cultures are overlapping with mechanisms of virus resistance. It is possible that ECM-mediated signaling affects the expression of cellular transcription factors that can regulate the expression of viral genes in a manner that is not favorable for the progression of the viral replication cycle after HSV-1 entry.
Interestingly, observations made in this study suggest that HSV-1 establishes quiescent infection in some tumor cells in 3D cultures. When OCM1 and C918 cells were inoculated with HSV-1 under 2D conditions and were then cultured within Matrigel, only a small minority of tumor cells that have taken up HSV-1 showed evidence of virus replication (GFP expression). As discussed earlier, these findings indicated that the viral replication cycle was inhibited at a post-entry step in the majority of infected tumor cells. Consequent growth of virus inoculated OCM1 cells in 3D cultures was associated with the establishment of multicellular tumor cell spheroids. Many OCM1 cells forming multicellular spheroids remained GFP negative throughout a 4-week observation period. However, the outgrowth of individual OCM1 cells into the Matrigel matrix from spheroids that have been GFP negative for days to weeks was often associated with the appearance of GFP expression in outgrowing cells and in cells within the spheroids. As Matrigel inhibits virus spread, reappearance of GFP expression in multicellular spheroids was very suggestive of virus reactivation from quiescence in earlier HSV-1 inoculated cells. It is well known that HSV-1 can establish quiescent infection in cultured non-neuronal cells if the progression of the viral replication cycle is blocked shortly after virus entry. 45, 46 However, establishment of quiescent infection in tumor cells induced by the ECM environment and reactivation of viral replication on changing tumor growth pattern have not been yet been reported. It will be of practical significance to determine whether similar processes also occur in vivo during HSV-1 oncolytic therapy.
In summary, observations reported here provide novel information about virus resistance of distinct tumor cell subpopulations in 3D tumor cell cultures and about mechanisms of ECM-mediated virus resistance of tumor cells. It is clear that additional studies will be required to fully understand the mechanisms by which the ECM mediates increased HSV-1 resistance of tumor cells in 3D cultures and to assess the clinical relevance of information collected in these cultures. However, our observations suggest that the experimental platform provided by 3D tumor cultures will be invaluable for studies aimed at the improvement and preclinical evaluation of viral oncolytic agents similarly to its usefulness in the case of chemotherapeutic agents and radiation therapy.
